Evaluating biomarkers in young adults with dementia from diverse backgrounds
Biomarker Evaluation in Young Onset Dementia from Diverse Populations (BEYONDD)
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-10670503
This study is looking to learn more about early onset dementia in younger adults, especially in Black and Latinx communities, by tracking health information and blood samples from 2,000 people under 65 over five years to help create better support and treatments for those affected.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-10670503 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding early onset dementia (EOD), particularly in Black and Latinx populations who are often underrepresented in studies. It aims to identify unique risk factors and resilience traits in these diverse groups by using plasma biomarkers and remote clinical assessments. The study will enroll 2,000 adults under 65 years old, with a significant portion from diverse populations, to gather comprehensive data over five years. This approach seeks to improve our understanding of EOD and tailor interventions accordingly.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults under 65 years old, especially those from Black and Latinx backgrounds who are experiencing early onset dementia.
Not a fit: Patients over 65 years old or those not belonging to the targeted diverse populations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better diagnostic tools and treatment strategies for young adults with dementia, particularly in underrepresented communities.
How similar studies have performed: While there have been studies on dementia, this research is novel in its focus on early onset dementia in diverse populations, addressing a significant gap in existing literature.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BOXER, ADAM L. — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: BOXER, ADAM L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.